-
-
-
ISO 9001:2015 CERTIFIED
Meet ASTANDARDS at
CPHI India : November 23-25, 2026
IICC Yashobhoomi, Dwarka, New Delhi, India
ISO 9001:2015 CERTIFIED
Meet ASTANDARDS at
CPHI India : November 23-25, 2026
IICC Yashobhoomi, Dwarka, New Delhi, India
Bortezomib API is a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It induces cancer cell apoptosis by disrupting protein degradation pathways and is manufactured under GMP standards for injectable formulations.
Bortezomib API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6 (Page 1 of 1)
CAT No.: AS02684
CAS No.: 1132709-14-8
Category: Impurities
Parent API: Bortezomib
Mol. Formula: C19H19ClF3NO5
Mol. Wt.: 384.24
CAT No.: AS02455
CAS No.: 289472-80-6
Category: Impurities
Parent API: Bortezomib
Mol. Formula: C17H26ClNO2
Mol. Wt.: 270.29
CAT No.: AS04017
CAS No.: 78-77-3
Category: Impurities
Parent API: Bortezomib
Mol. Formula: C18H19Cl2NO4
Mol. Wt.: 137
CAT No.: AS02454
CAS No.: 289472-78-2
Category: Impurities
Parent API: Bortezomib
Mol. Formula: C14H14N4O2
Mol. Wt.: 356.43
CAT No.: AS02453
CAS No.: 114457-94-2
Category: Impurities
Parent API: Bortezomib
Mol. Formula: C19H24N4O3
Mol. Wt.: 271.28
CAT No.: AS01667
CAS No.: 179324-69-7
Category: Working Standards
Parent API: Bortezomib
Mol. Formula: C19H25BN4O4
Mol. Wt.: 384.24
